keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(Ala13)-Apelin-13 acetate, an APJ antagonist, modulates CRF-induced enhanced colonic motility, visceral sensation, and gut barrier.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
2 mg | お問い合わせ | ¥ 27,000 |
5 mg | お問い合わせ | ¥ 39,000 |
10 mg | お問い合わせ | ¥ 62,500 |
25 mg | お問い合わせ | ¥ 119,000 |
50 mg | お問い合わせ | ¥ 179,000 |
100 mg | お問い合わせ | ¥ 268,500 |
200 mg | お問い合わせ | ¥ 403,000 |
500 mg | お問い合わせ | ¥ 765,500 |
説明 | (Ala13)-Apelin-13 acetate, an APJ antagonist, modulates CRF-induced enhanced colonic motility, visceral sensation, and gut barrier. |
In vivo | (Ala13)-Apelin-13 acetate (i.p.)blocked lipopolysaccharide (LPS)- or CRF-induced visceral hypersensitivity and colonic hyperpermeability (IBS model) in a dose-response manner[1]. |
分子量 | 1534.79 |
分子式 | C65H111N23O18S |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(Ala13)-Apelin-13 acetate GPCR/G Protein Apelin receptor (Ala13) Apelin 13 acetate (Ala13)Apelin13 acetate (Ala-13)-Apelin-13 acetate (568565-11-7 Free base) (Ala13)-Apelin-13 Acetate Inhibitor inhibitor inhibit